ARDC Research Link Australia

ORCID Profile
Orcid icon. 0000-0003-2009-270X

Current Organisations
Massachsuetts Institute of Technology , Harvard Medical School , Harvard-MIT Division of Health Sciences and Technology , Boston University School of Medicine , Brigham and Women's Hospital

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.

Publications

Publication

Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy

Publisher: American Chemical Society (ACS)

Date: 28-11-2019

DOI: 10.1021/ACSNANO.8B06400

Publication

Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy

Publisher: American Chemical Society (ACS)

Date: 03-02-2020

DOI: 10.1021/ACS.NANOLETT.9B04683

Publication

Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy

Publisher: American Chemical Society (ACS)

Date: 02-11-2021

DOI: 10.1021/ACS.NANOLETT.1C03988

Publication

Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis

Publisher: American Chemical Society (ACS)

Date: 28-04-2016

DOI: 10.1021/ACSNANO.6B01114

Publication

Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems

Publisher: American Chemical Society (ACS)

Date: 14-07-2017

DOI: 10.1021/ACS.BIOMAC.7B00803

Abstract: After more than 20 years of intensive investigations, gene therapy has become one of the most promising strategies for treating genetic diseases. However, the lack of ideal delivery systems has limited the clinical realization of gene therapy's tremendous potential, especially for DNA-based gene therapy. Over the past decade, considerable advances have been made in the application of polymer-based DNA delivery systems for gene therapy, especially through multifunctional systems. The core concept behind multifunctional polymeric DNA delivery systems is to endow one single DNA carrier, via materials engineering and surface modification, with several active functions, e.g., good cargo DNA protection, excellent colloidal stability, high cellular uptake efficiency, efficient endo/lysosome escape, effective import into the nucleus, and DNA unpacking. Such specially developed vectors would be capable of overcoming multiple barriers to the successful delivery of DNA. In this review, we first provide a comprehensive overview of the interactions between the protein corona and DNA vectors, the mechanisms and challenges of nonviral DNA vectors, and important concepts in the design of DNA carriers identified via past reports on DNA delivery systems. Finally, we highlight and discuss recent advances in multifunctional polymeric DNA delivery systems based on "off-the-shelf" polycations including polyethylenimine (PEI), poly-l-lysine (PLL), and chitosan and offer perspectives on future developments.